Dashboard
Manage Tickers

CLDXCelldex Therapeutics, Inc.

Nasdaq celldex.com


$ 36.04 $ 0.44 (1.24 %)    

Wednesday, 12-Jun-2024 15:59:46 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 476.76 $ 6.13 (1.31 %)
DIA $ 387.57 $ -0.28 (-0.07 %)
SPY $ 541.15 $ 4.41 (0.82 %)
TLT $ 92.53 $ 0.69 (0.75 %)
GLD $ 214.71 $ 0.57 (0.27 %)
$ 36.01
$ 37.06
$ 32.40 x 100
$ 39.48 x 100
$ 35.67 - $ 37.10
$ 22.11 - $ 53.18
659,326
na
2.12B
$ 0.82
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-06-2024 03-31-2024 10-Q
2 02-26-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 03-29-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 03-26-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-07-2019 03-31-2019 10-Q
22 03-07-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-08-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-07-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-08-2017 06-30-2017 10-Q
29 05-09-2017 03-31-2017 10-Q
30 03-14-2017 12-31-2016 10-K
31 11-07-2016 09-30-2016 10-Q
32 08-08-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 02-23-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-10-2015 06-30-2015 10-Q
37 04-29-2015 03-31-2015 10-Q
38 02-24-2015 12-31-2014 10-K
39 11-05-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wolfe-research-initiates-coverage-on-celldex-therapeutics-with-outperform-rating
Wolfe Research Initiates Coverage On Celld...
06/11/2024 18:13:38

Wolfe Research analyst Andy Chen initiates coverage on Celldex Therapeutics (NASDAQ:CLDX) with a Outperform rating.

analyst-expectations-for-celldex-therapeuticss-future
Analyst Expectations For Celldex Therapeut...
06/03/2024 12:00:29

hc-wainwright--co-reiterates-buy-on-celldex-therapeutics-maintains-80-price-target
HC Wainwright & Co. Reiterates Buy on Cell...
06/03/2024 11:15:10

HC Wainwright & Co. analyst Joseph Pantginis reiterates Celldex Therapeutics (NASDAQ:CLDX) with a Buy and maintains $80 ...

celldex-therapeutics-reported--data-showing-barzolvolimab-improves-angioedema-at-12-weeks-in-phase-2-study-for-chronic-spontaneous-urticaria
Celldex Therapeutics Reported Data Showin...
06/02/2024 14:01:04

Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced data demonstrating that barzolvolimab profoundly improves angioedema a...

hc-wainwright--co-reiterates-buy-on-celldex-therapeutics-maintains-80-price-target
HC Wainwright & Co. Reiterates Buy on Cell...
05/15/2024 14:40:48

HC Wainwright & Co. analyst Joseph Pantginis reiterates Celldex Therapeutics (NASDAQ:CLDX) with a Buy and maintains $80 ...

celldex-doses-first-patient-in-phase-2-study-of-barzolvolimab-in-prurigo-nodularis
Celldex Doses First Patient In Phase 2 Stu...
05/15/2024 12:02:22

unveiling-4-analyst-insights-on-celldex-therapeutics
Unveiling 4 Analyst Insights On Celldex Th...
05/07/2024 20:00:33

hc-wainwright--co-reiterates-buy-on-celldex-therapeutics-maintains-80-price-target
HC Wainwright & Co. Reiterates Buy on Cell...
05/07/2024 10:55:07

HC Wainwright & Co. analyst Joseph Pantginis reiterates Celldex Therapeutics (NASDAQ:CLDX) with a Buy and maintains $80 ...

celldex-therapeutics-q1-eps-056-beats-069-estimate-sales-15600k-miss-92000k-estimate
Celldex Therapeutics Q1 EPS $(0.56) Beats ...
05/06/2024 20:04:49

Celldex Therapeutics (NASDAQ:CLDX) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of ...

hc-wainwright--co-reiterates-buy-on-celldex-therapeutics-maintains-80-price-target
HC Wainwright & Co. Reiterates Buy on Cell...
04/17/2024 14:35:54

HC Wainwright & Co. analyst Joseph Pantginis reiterates Celldex Therapeutics (NASDAQ:CLDX) with a Buy and maintains $80 ...

celldex-completes-enrollment-in-phase-2-study-of-barzolvolimab-in-patients-with-chronic-inducible-urticaria
Celldex Completes Enrollment In Phase 2 St...
04/17/2024 12:01:49

cantor-fitzgerald-reiterates-overweight-on-celldex-therapeutics-maintains-67-price-target
Cantor Fitzgerald Reiterates Overweight on...
03/22/2024 17:51:56

Cantor Fitzgerald analyst Kristen Kluska reiterates Celldex Therapeutics (NASDAQ:CLDX) with a Overweight and maintains $67 p...

Core News & Articles
Market-Moving News for March 15th
03/15/2024 12:36:47

MDGL: 28% | Madrigal Pharmaceuticals shares are trading higher after the company announced FDA approval of Rezdiffra for the tr...

cooper-companies-reports-upbeat-results-joins-dell-netapp-tidewater-and-other-big-stocks-moving-higher-on-friday
Cooper Companies Reports Upbeat Results, J...
03/01/2024 16:18:21

U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday.

reported-earlier-celldex-therapeutics-prices-upsized-400m-public-offering-of-852m-common-stock-at-47share
Reported Earlier, Celldex Therapeutics Pri...
03/01/2024 08:06:21

In connection with the offering, Celldex has granted the underwriters a 30-day option to purchase up to an additional 1,278,000...

celldex-therapeutics-proposes-to-offer-and-sell-250m-of-shares-of-its-common-stock-via-public-offering
Celldex Therapeutics Proposes To Offer And...
02/28/2024 21:02:26

All of the shares of common stock are being offered by the Company.

guggenheim-maintains-buy-on-celldex-therapeutics-raises-price-target-to-90
Guggenheim Maintains Buy on Celldex Therap...
02/27/2024 17:04:44

Guggenheim analyst Yatin Suneja maintains Celldex Therapeutics (NASDAQ:CLDX) with a Buy and raises the price target from $72...

why-freshpet-shares-are-trading-higher-by-around-15-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Freshpet Shares Are Trading Higher By ...
02/26/2024 18:57:55

Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter...

celldex-therapeutics-q4-earnings-insights
Celldex Therapeutics: Q4 Earnings Insights
02/26/2024 16:55:05

celldex-therapeutics-entered-deal-to-sell-shares-of-up-to-300m-common-stock-offering-from-time-to-time
Celldex Therapeutics Entered Deal To Sell ...
02/26/2024 14:58:29

- SEC Filing

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)